Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
31,654
archived clinical trials in
Cardiology

Effect of CER-001 on Atherosclerosis in Acute Coronary Syndrome (ACS) Patients - Efficacy and Safety: The CHI SQUARE Trial
CHI SQUARE: Can HDL Infusions Significantly Quicken Atherosclerosis Regression? A Phase II, Multi-Center, Double-Blind, Ascending Dose, Placebo-Controlled, Dose-Finding Trial of CER-001 or Placebo in Subjects With Acute Coronary Syndrome
Status: Enrolling
Updated:  6/14/2012
Mayo Clinic
mi
from
Phoenix, AZ
Effect of CER-001 on Atherosclerosis in Acute Coronary Syndrome (ACS) Patients - Efficacy and Safety: The CHI SQUARE Trial
CHI SQUARE: Can HDL Infusions Significantly Quicken Atherosclerosis Regression? A Phase II, Multi-Center, Double-Blind, Ascending Dose, Placebo-Controlled, Dose-Finding Trial of CER-001 or Placebo in Subjects With Acute Coronary Syndrome
Status: Enrolling
Updated: 6/14/2012
Mayo Clinic
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Effect of CER-001 on Atherosclerosis in Acute Coronary Syndrome (ACS) Patients - Efficacy and Safety: The CHI SQUARE Trial
CHI SQUARE: Can HDL Infusions Significantly Quicken Atherosclerosis Regression? A Phase II, Multi-Center, Double-Blind, Ascending Dose, Placebo-Controlled, Dose-Finding Trial of CER-001 or Placebo in Subjects With Acute Coronary Syndrome
Status: Enrolling
Updated:  6/14/2012
VA San Diego Health Care Center
mi
from
San Diego, CA
Effect of CER-001 on Atherosclerosis in Acute Coronary Syndrome (ACS) Patients - Efficacy and Safety: The CHI SQUARE Trial
CHI SQUARE: Can HDL Infusions Significantly Quicken Atherosclerosis Regression? A Phase II, Multi-Center, Double-Blind, Ascending Dose, Placebo-Controlled, Dose-Finding Trial of CER-001 or Placebo in Subjects With Acute Coronary Syndrome
Status: Enrolling
Updated: 6/14/2012
VA San Diego Health Care Center
mi
from
San Diego, CA
Click here to add this to my saved trials
Effect of CER-001 on Atherosclerosis in Acute Coronary Syndrome (ACS) Patients - Efficacy and Safety: The CHI SQUARE Trial
CHI SQUARE: Can HDL Infusions Significantly Quicken Atherosclerosis Regression? A Phase II, Multi-Center, Double-Blind, Ascending Dose, Placebo-Controlled, Dose-Finding Trial of CER-001 or Placebo in Subjects With Acute Coronary Syndrome
Status: Enrolling
Updated:  6/14/2012
Palm Beach Heart Institute, LLC - Zasa Clinical Research
mi
from
Boynton Beach, FL
Effect of CER-001 on Atherosclerosis in Acute Coronary Syndrome (ACS) Patients - Efficacy and Safety: The CHI SQUARE Trial
CHI SQUARE: Can HDL Infusions Significantly Quicken Atherosclerosis Regression? A Phase II, Multi-Center, Double-Blind, Ascending Dose, Placebo-Controlled, Dose-Finding Trial of CER-001 or Placebo in Subjects With Acute Coronary Syndrome
Status: Enrolling
Updated: 6/14/2012
Palm Beach Heart Institute, LLC - Zasa Clinical Research
mi
from
Boynton Beach, FL
Click here to add this to my saved trials
Effect of CER-001 on Atherosclerosis in Acute Coronary Syndrome (ACS) Patients - Efficacy and Safety: The CHI SQUARE Trial
CHI SQUARE: Can HDL Infusions Significantly Quicken Atherosclerosis Regression? A Phase II, Multi-Center, Double-Blind, Ascending Dose, Placebo-Controlled, Dose-Finding Trial of CER-001 or Placebo in Subjects With Acute Coronary Syndrome
Status: Enrolling
Updated:  6/14/2012
The Heart & Vascular Institute Of Florida
mi
from
Clearwater, FL
Effect of CER-001 on Atherosclerosis in Acute Coronary Syndrome (ACS) Patients - Efficacy and Safety: The CHI SQUARE Trial
CHI SQUARE: Can HDL Infusions Significantly Quicken Atherosclerosis Regression? A Phase II, Multi-Center, Double-Blind, Ascending Dose, Placebo-Controlled, Dose-Finding Trial of CER-001 or Placebo in Subjects With Acute Coronary Syndrome
Status: Enrolling
Updated: 6/14/2012
The Heart & Vascular Institute Of Florida
mi
from
Clearwater, FL
Click here to add this to my saved trials
Effect of CER-001 on Atherosclerosis in Acute Coronary Syndrome (ACS) Patients - Efficacy and Safety: The CHI SQUARE Trial
CHI SQUARE: Can HDL Infusions Significantly Quicken Atherosclerosis Regression? A Phase II, Multi-Center, Double-Blind, Ascending Dose, Placebo-Controlled, Dose-Finding Trial of CER-001 or Placebo in Subjects With Acute Coronary Syndrome
Status: Enrolling
Updated:  6/14/2012
Jacksonville Center for Clinical Research
mi
from
Jacksonville, FL
Effect of CER-001 on Atherosclerosis in Acute Coronary Syndrome (ACS) Patients - Efficacy and Safety: The CHI SQUARE Trial
CHI SQUARE: Can HDL Infusions Significantly Quicken Atherosclerosis Regression? A Phase II, Multi-Center, Double-Blind, Ascending Dose, Placebo-Controlled, Dose-Finding Trial of CER-001 or Placebo in Subjects With Acute Coronary Syndrome
Status: Enrolling
Updated: 6/14/2012
Jacksonville Center for Clinical Research
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Effect of CER-001 on Atherosclerosis in Acute Coronary Syndrome (ACS) Patients - Efficacy and Safety: The CHI SQUARE Trial
CHI SQUARE: Can HDL Infusions Significantly Quicken Atherosclerosis Regression? A Phase II, Multi-Center, Double-Blind, Ascending Dose, Placebo-Controlled, Dose-Finding Trial of CER-001 or Placebo in Subjects With Acute Coronary Syndrome
Status: Enrolling
Updated:  6/14/2012
Orlando Heart Center
mi
from
Orlando, FL
Effect of CER-001 on Atherosclerosis in Acute Coronary Syndrome (ACS) Patients - Efficacy and Safety: The CHI SQUARE Trial
CHI SQUARE: Can HDL Infusions Significantly Quicken Atherosclerosis Regression? A Phase II, Multi-Center, Double-Blind, Ascending Dose, Placebo-Controlled, Dose-Finding Trial of CER-001 or Placebo in Subjects With Acute Coronary Syndrome
Status: Enrolling
Updated: 6/14/2012
Orlando Heart Center
mi
from
Orlando, FL
Click here to add this to my saved trials
Effect of CER-001 on Atherosclerosis in Acute Coronary Syndrome (ACS) Patients - Efficacy and Safety: The CHI SQUARE Trial
CHI SQUARE: Can HDL Infusions Significantly Quicken Atherosclerosis Regression? A Phase II, Multi-Center, Double-Blind, Ascending Dose, Placebo-Controlled, Dose-Finding Trial of CER-001 or Placebo in Subjects With Acute Coronary Syndrome
Status: Enrolling
Updated:  6/14/2012
Saint Joseph Research Institute
mi
from
Atlanta, GA
Effect of CER-001 on Atherosclerosis in Acute Coronary Syndrome (ACS) Patients - Efficacy and Safety: The CHI SQUARE Trial
CHI SQUARE: Can HDL Infusions Significantly Quicken Atherosclerosis Regression? A Phase II, Multi-Center, Double-Blind, Ascending Dose, Placebo-Controlled, Dose-Finding Trial of CER-001 or Placebo in Subjects With Acute Coronary Syndrome
Status: Enrolling
Updated: 6/14/2012
Saint Joseph Research Institute
mi
from
Atlanta, GA
Click here to add this to my saved trials
Effect of CER-001 on Atherosclerosis in Acute Coronary Syndrome (ACS) Patients - Efficacy and Safety: The CHI SQUARE Trial
CHI SQUARE: Can HDL Infusions Significantly Quicken Atherosclerosis Regression? A Phase II, Multi-Center, Double-Blind, Ascending Dose, Placebo-Controlled, Dose-Finding Trial of CER-001 or Placebo in Subjects With Acute Coronary Syndrome
Status: Enrolling
Updated:  6/14/2012
The Care Group, LLC
mi
from
Indianapolis, IN
Effect of CER-001 on Atherosclerosis in Acute Coronary Syndrome (ACS) Patients - Efficacy and Safety: The CHI SQUARE Trial
CHI SQUARE: Can HDL Infusions Significantly Quicken Atherosclerosis Regression? A Phase II, Multi-Center, Double-Blind, Ascending Dose, Placebo-Controlled, Dose-Finding Trial of CER-001 or Placebo in Subjects With Acute Coronary Syndrome
Status: Enrolling
Updated: 6/14/2012
The Care Group, LLC
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Effect of CER-001 on Atherosclerosis in Acute Coronary Syndrome (ACS) Patients - Efficacy and Safety: The CHI SQUARE Trial
CHI SQUARE: Can HDL Infusions Significantly Quicken Atherosclerosis Regression? A Phase II, Multi-Center, Double-Blind, Ascending Dose, Placebo-Controlled, Dose-Finding Trial of CER-001 or Placebo in Subjects With Acute Coronary Syndrome
Status: Enrolling
Updated:  6/14/2012
TCA Research LLC
mi
from
Covington, LA
Effect of CER-001 on Atherosclerosis in Acute Coronary Syndrome (ACS) Patients - Efficacy and Safety: The CHI SQUARE Trial
CHI SQUARE: Can HDL Infusions Significantly Quicken Atherosclerosis Regression? A Phase II, Multi-Center, Double-Blind, Ascending Dose, Placebo-Controlled, Dose-Finding Trial of CER-001 or Placebo in Subjects With Acute Coronary Syndrome
Status: Enrolling
Updated: 6/14/2012
TCA Research LLC
mi
from
Covington, LA
Click here to add this to my saved trials
Effect of CER-001 on Atherosclerosis in Acute Coronary Syndrome (ACS) Patients - Efficacy and Safety: The CHI SQUARE Trial
CHI SQUARE: Can HDL Infusions Significantly Quicken Atherosclerosis Regression? A Phase II, Multi-Center, Double-Blind, Ascending Dose, Placebo-Controlled, Dose-Finding Trial of CER-001 or Placebo in Subjects With Acute Coronary Syndrome
Status: Enrolling
Updated:  6/14/2012
Johns Hopkins Hospital
mi
from
Baltimore, MD
Effect of CER-001 on Atherosclerosis in Acute Coronary Syndrome (ACS) Patients - Efficacy and Safety: The CHI SQUARE Trial
CHI SQUARE: Can HDL Infusions Significantly Quicken Atherosclerosis Regression? A Phase II, Multi-Center, Double-Blind, Ascending Dose, Placebo-Controlled, Dose-Finding Trial of CER-001 or Placebo in Subjects With Acute Coronary Syndrome
Status: Enrolling
Updated: 6/14/2012
Johns Hopkins Hospital
mi
from
Baltimore, MD
Click here to add this to my saved trials
Effect of CER-001 on Atherosclerosis in Acute Coronary Syndrome (ACS) Patients - Efficacy and Safety: The CHI SQUARE Trial
CHI SQUARE: Can HDL Infusions Significantly Quicken Atherosclerosis Regression? A Phase II, Multi-Center, Double-Blind, Ascending Dose, Placebo-Controlled, Dose-Finding Trial of CER-001 or Placebo in Subjects With Acute Coronary Syndrome
Status: Enrolling
Updated:  6/14/2012
Suburban Hospital
mi
from
Bethesda, MD
Effect of CER-001 on Atherosclerosis in Acute Coronary Syndrome (ACS) Patients - Efficacy and Safety: The CHI SQUARE Trial
CHI SQUARE: Can HDL Infusions Significantly Quicken Atherosclerosis Regression? A Phase II, Multi-Center, Double-Blind, Ascending Dose, Placebo-Controlled, Dose-Finding Trial of CER-001 or Placebo in Subjects With Acute Coronary Syndrome
Status: Enrolling
Updated: 6/14/2012
Suburban Hospital
mi
from
Bethesda, MD
Click here to add this to my saved trials
Effect of CER-001 on Atherosclerosis in Acute Coronary Syndrome (ACS) Patients - Efficacy and Safety: The CHI SQUARE Trial
CHI SQUARE: Can HDL Infusions Significantly Quicken Atherosclerosis Regression? A Phase II, Multi-Center, Double-Blind, Ascending Dose, Placebo-Controlled, Dose-Finding Trial of CER-001 or Placebo in Subjects With Acute Coronary Syndrome
Status: Enrolling
Updated:  6/14/2012
University of Michigan Health System
mi
from
Ann Arbor, MI
Effect of CER-001 on Atherosclerosis in Acute Coronary Syndrome (ACS) Patients - Efficacy and Safety: The CHI SQUARE Trial
CHI SQUARE: Can HDL Infusions Significantly Quicken Atherosclerosis Regression? A Phase II, Multi-Center, Double-Blind, Ascending Dose, Placebo-Controlled, Dose-Finding Trial of CER-001 or Placebo in Subjects With Acute Coronary Syndrome
Status: Enrolling
Updated: 6/14/2012
University of Michigan Health System
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Effect of CER-001 on Atherosclerosis in Acute Coronary Syndrome (ACS) Patients - Efficacy and Safety: The CHI SQUARE Trial
CHI SQUARE: Can HDL Infusions Significantly Quicken Atherosclerosis Regression? A Phase II, Multi-Center, Double-Blind, Ascending Dose, Placebo-Controlled, Dose-Finding Trial of CER-001 or Placebo in Subjects With Acute Coronary Syndrome
Status: Enrolling
Updated:  6/14/2012
Detroit Medical Center (DMC) Cardiovascular Institute
mi
from
Detroit, MI
Effect of CER-001 on Atherosclerosis in Acute Coronary Syndrome (ACS) Patients - Efficacy and Safety: The CHI SQUARE Trial
CHI SQUARE: Can HDL Infusions Significantly Quicken Atherosclerosis Regression? A Phase II, Multi-Center, Double-Blind, Ascending Dose, Placebo-Controlled, Dose-Finding Trial of CER-001 or Placebo in Subjects With Acute Coronary Syndrome
Status: Enrolling
Updated: 6/14/2012
Detroit Medical Center (DMC) Cardiovascular Institute
mi
from
Detroit, MI
Click here to add this to my saved trials
Effect of CER-001 on Atherosclerosis in Acute Coronary Syndrome (ACS) Patients - Efficacy and Safety: The CHI SQUARE Trial
CHI SQUARE: Can HDL Infusions Significantly Quicken Atherosclerosis Regression? A Phase II, Multi-Center, Double-Blind, Ascending Dose, Placebo-Controlled, Dose-Finding Trial of CER-001 or Placebo in Subjects With Acute Coronary Syndrome
Status: Enrolling
Updated:  6/14/2012
Cardiac and Vascular Research Center of Northern Michigan
mi
from
Petoskey, MI
Effect of CER-001 on Atherosclerosis in Acute Coronary Syndrome (ACS) Patients - Efficacy and Safety: The CHI SQUARE Trial
CHI SQUARE: Can HDL Infusions Significantly Quicken Atherosclerosis Regression? A Phase II, Multi-Center, Double-Blind, Ascending Dose, Placebo-Controlled, Dose-Finding Trial of CER-001 or Placebo in Subjects With Acute Coronary Syndrome
Status: Enrolling
Updated: 6/14/2012
Cardiac and Vascular Research Center of Northern Michigan
mi
from
Petoskey, MI
Click here to add this to my saved trials
Effect of CER-001 on Atherosclerosis in Acute Coronary Syndrome (ACS) Patients - Efficacy and Safety: The CHI SQUARE Trial
CHI SQUARE: Can HDL Infusions Significantly Quicken Atherosclerosis Regression? A Phase II, Multi-Center, Double-Blind, Ascending Dose, Placebo-Controlled, Dose-Finding Trial of CER-001 or Placebo in Subjects With Acute Coronary Syndrome
Status: Enrolling
Updated:  6/14/2012
Alegent Research Center
mi
from
Omaha, NE
Effect of CER-001 on Atherosclerosis in Acute Coronary Syndrome (ACS) Patients - Efficacy and Safety: The CHI SQUARE Trial
CHI SQUARE: Can HDL Infusions Significantly Quicken Atherosclerosis Regression? A Phase II, Multi-Center, Double-Blind, Ascending Dose, Placebo-Controlled, Dose-Finding Trial of CER-001 or Placebo in Subjects With Acute Coronary Syndrome
Status: Enrolling
Updated: 6/14/2012
Alegent Research Center
mi
from
Omaha, NE
Click here to add this to my saved trials
Effect of CER-001 on Atherosclerosis in Acute Coronary Syndrome (ACS) Patients - Efficacy and Safety: The CHI SQUARE Trial
CHI SQUARE: Can HDL Infusions Significantly Quicken Atherosclerosis Regression? A Phase II, Multi-Center, Double-Blind, Ascending Dose, Placebo-Controlled, Dose-Finding Trial of CER-001 or Placebo in Subjects With Acute Coronary Syndrome
Status: Enrolling
Updated:  6/14/2012
Buffalo Heart Group, LLC
mi
from
Buffalo, NY
Effect of CER-001 on Atherosclerosis in Acute Coronary Syndrome (ACS) Patients - Efficacy and Safety: The CHI SQUARE Trial
CHI SQUARE: Can HDL Infusions Significantly Quicken Atherosclerosis Regression? A Phase II, Multi-Center, Double-Blind, Ascending Dose, Placebo-Controlled, Dose-Finding Trial of CER-001 or Placebo in Subjects With Acute Coronary Syndrome
Status: Enrolling
Updated: 6/14/2012
Buffalo Heart Group, LLC
mi
from
Buffalo, NY
Click here to add this to my saved trials
Effect of CER-001 on Atherosclerosis in Acute Coronary Syndrome (ACS) Patients - Efficacy and Safety: The CHI SQUARE Trial
CHI SQUARE: Can HDL Infusions Significantly Quicken Atherosclerosis Regression? A Phase II, Multi-Center, Double-Blind, Ascending Dose, Placebo-Controlled, Dose-Finding Trial of CER-001 or Placebo in Subjects With Acute Coronary Syndrome
Status: Enrolling
Updated:  6/14/2012
Buffalo Cardiology & Pulmonary Associates
mi
from
Williamsville, NY
Effect of CER-001 on Atherosclerosis in Acute Coronary Syndrome (ACS) Patients - Efficacy and Safety: The CHI SQUARE Trial
CHI SQUARE: Can HDL Infusions Significantly Quicken Atherosclerosis Regression? A Phase II, Multi-Center, Double-Blind, Ascending Dose, Placebo-Controlled, Dose-Finding Trial of CER-001 or Placebo in Subjects With Acute Coronary Syndrome
Status: Enrolling
Updated: 6/14/2012
Buffalo Cardiology & Pulmonary Associates
mi
from
Williamsville, NY
Click here to add this to my saved trials
Effect of CER-001 on Atherosclerosis in Acute Coronary Syndrome (ACS) Patients - Efficacy and Safety: The CHI SQUARE Trial
CHI SQUARE: Can HDL Infusions Significantly Quicken Atherosclerosis Regression? A Phase II, Multi-Center, Double-Blind, Ascending Dose, Placebo-Controlled, Dose-Finding Trial of CER-001 or Placebo in Subjects With Acute Coronary Syndrome
Status: Enrolling
Updated:  6/14/2012
University of North Carolina Medical Center
mi
from
Chapel Hill, NC
Effect of CER-001 on Atherosclerosis in Acute Coronary Syndrome (ACS) Patients - Efficacy and Safety: The CHI SQUARE Trial
CHI SQUARE: Can HDL Infusions Significantly Quicken Atherosclerosis Regression? A Phase II, Multi-Center, Double-Blind, Ascending Dose, Placebo-Controlled, Dose-Finding Trial of CER-001 or Placebo in Subjects With Acute Coronary Syndrome
Status: Enrolling
Updated: 6/14/2012
University of North Carolina Medical Center
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Effect of CER-001 on Atherosclerosis in Acute Coronary Syndrome (ACS) Patients - Efficacy and Safety: The CHI SQUARE Trial
CHI SQUARE: Can HDL Infusions Significantly Quicken Atherosclerosis Regression? A Phase II, Multi-Center, Double-Blind, Ascending Dose, Placebo-Controlled, Dose-Finding Trial of CER-001 or Placebo in Subjects With Acute Coronary Syndrome
Status: Enrolling
Updated:  6/14/2012
LeBauer Cardiovascular Research Foundation
mi
from
Greensboro, NC
Effect of CER-001 on Atherosclerosis in Acute Coronary Syndrome (ACS) Patients - Efficacy and Safety: The CHI SQUARE Trial
CHI SQUARE: Can HDL Infusions Significantly Quicken Atherosclerosis Regression? A Phase II, Multi-Center, Double-Blind, Ascending Dose, Placebo-Controlled, Dose-Finding Trial of CER-001 or Placebo in Subjects With Acute Coronary Syndrome
Status: Enrolling
Updated: 6/14/2012
LeBauer Cardiovascular Research Foundation
mi
from
Greensboro, NC
Click here to add this to my saved trials
Effect of CER-001 on Atherosclerosis in Acute Coronary Syndrome (ACS) Patients - Efficacy and Safety: The CHI SQUARE Trial
CHI SQUARE: Can HDL Infusions Significantly Quicken Atherosclerosis Regression? A Phase II, Multi-Center, Double-Blind, Ascending Dose, Placebo-Controlled, Dose-Finding Trial of CER-001 or Placebo in Subjects With Acute Coronary Syndrome
Status: Enrolling
Updated:  6/14/2012
Sanford Heart Center
mi
from
Fargo, ND
Effect of CER-001 on Atherosclerosis in Acute Coronary Syndrome (ACS) Patients - Efficacy and Safety: The CHI SQUARE Trial
CHI SQUARE: Can HDL Infusions Significantly Quicken Atherosclerosis Regression? A Phase II, Multi-Center, Double-Blind, Ascending Dose, Placebo-Controlled, Dose-Finding Trial of CER-001 or Placebo in Subjects With Acute Coronary Syndrome
Status: Enrolling
Updated: 6/14/2012
Sanford Heart Center
mi
from
Fargo, ND
Click here to add this to my saved trials
Effect of CER-001 on Atherosclerosis in Acute Coronary Syndrome (ACS) Patients - Efficacy and Safety: The CHI SQUARE Trial
CHI SQUARE: Can HDL Infusions Significantly Quicken Atherosclerosis Regression? A Phase II, Multi-Center, Double-Blind, Ascending Dose, Placebo-Controlled, Dose-Finding Trial of CER-001 or Placebo in Subjects With Acute Coronary Syndrome
Status: Enrolling
Updated:  6/14/2012
North Ohio Research, Ltd.
mi
from
Elyria, OH
Effect of CER-001 on Atherosclerosis in Acute Coronary Syndrome (ACS) Patients - Efficacy and Safety: The CHI SQUARE Trial
CHI SQUARE: Can HDL Infusions Significantly Quicken Atherosclerosis Regression? A Phase II, Multi-Center, Double-Blind, Ascending Dose, Placebo-Controlled, Dose-Finding Trial of CER-001 or Placebo in Subjects With Acute Coronary Syndrome
Status: Enrolling
Updated: 6/14/2012
North Ohio Research, Ltd.
mi
from
Elyria, OH
Click here to add this to my saved trials
Effect of CER-001 on Atherosclerosis in Acute Coronary Syndrome (ACS) Patients - Efficacy and Safety: The CHI SQUARE Trial
CHI SQUARE: Can HDL Infusions Significantly Quicken Atherosclerosis Regression? A Phase II, Multi-Center, Double-Blind, Ascending Dose, Placebo-Controlled, Dose-Finding Trial of CER-001 or Placebo in Subjects With Acute Coronary Syndrome
Status: Enrolling
Updated:  6/14/2012
South Oklahoma Heart Research
mi
from
Oklahoma City, OK
Effect of CER-001 on Atherosclerosis in Acute Coronary Syndrome (ACS) Patients - Efficacy and Safety: The CHI SQUARE Trial
CHI SQUARE: Can HDL Infusions Significantly Quicken Atherosclerosis Regression? A Phase II, Multi-Center, Double-Blind, Ascending Dose, Placebo-Controlled, Dose-Finding Trial of CER-001 or Placebo in Subjects With Acute Coronary Syndrome
Status: Enrolling
Updated: 6/14/2012
South Oklahoma Heart Research
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Effect of CER-001 on Atherosclerosis in Acute Coronary Syndrome (ACS) Patients - Efficacy and Safety: The CHI SQUARE Trial
CHI SQUARE: Can HDL Infusions Significantly Quicken Atherosclerosis Regression? A Phase II, Multi-Center, Double-Blind, Ascending Dose, Placebo-Controlled, Dose-Finding Trial of CER-001 or Placebo in Subjects With Acute Coronary Syndrome
Status: Enrolling
Updated:  6/14/2012
Penn Presbyterian Medical Center
mi
from
Philadelphia, PA
Effect of CER-001 on Atherosclerosis in Acute Coronary Syndrome (ACS) Patients - Efficacy and Safety: The CHI SQUARE Trial
CHI SQUARE: Can HDL Infusions Significantly Quicken Atherosclerosis Regression? A Phase II, Multi-Center, Double-Blind, Ascending Dose, Placebo-Controlled, Dose-Finding Trial of CER-001 or Placebo in Subjects With Acute Coronary Syndrome
Status: Enrolling
Updated: 6/14/2012
Penn Presbyterian Medical Center
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Effect of CER-001 on Atherosclerosis in Acute Coronary Syndrome (ACS) Patients - Efficacy and Safety: The CHI SQUARE Trial
CHI SQUARE: Can HDL Infusions Significantly Quicken Atherosclerosis Regression? A Phase II, Multi-Center, Double-Blind, Ascending Dose, Placebo-Controlled, Dose-Finding Trial of CER-001 or Placebo in Subjects With Acute Coronary Syndrome
Status: Enrolling
Updated:  6/14/2012
Sanford Research/USD
mi
from
Sioux Falls, SD
Effect of CER-001 on Atherosclerosis in Acute Coronary Syndrome (ACS) Patients - Efficacy and Safety: The CHI SQUARE Trial
CHI SQUARE: Can HDL Infusions Significantly Quicken Atherosclerosis Regression? A Phase II, Multi-Center, Double-Blind, Ascending Dose, Placebo-Controlled, Dose-Finding Trial of CER-001 or Placebo in Subjects With Acute Coronary Syndrome
Status: Enrolling
Updated: 6/14/2012
Sanford Research/USD
mi
from
Sioux Falls, SD
Click here to add this to my saved trials
Effect of CER-001 on Atherosclerosis in Acute Coronary Syndrome (ACS) Patients - Efficacy and Safety: The CHI SQUARE Trial
CHI SQUARE: Can HDL Infusions Significantly Quicken Atherosclerosis Regression? A Phase II, Multi-Center, Double-Blind, Ascending Dose, Placebo-Controlled, Dose-Finding Trial of CER-001 or Placebo in Subjects With Acute Coronary Syndrome
Status: Enrolling
Updated:  6/14/2012
Baptist Memorial Hospital
mi
from
Memphis, TN
Effect of CER-001 on Atherosclerosis in Acute Coronary Syndrome (ACS) Patients - Efficacy and Safety: The CHI SQUARE Trial
CHI SQUARE: Can HDL Infusions Significantly Quicken Atherosclerosis Regression? A Phase II, Multi-Center, Double-Blind, Ascending Dose, Placebo-Controlled, Dose-Finding Trial of CER-001 or Placebo in Subjects With Acute Coronary Syndrome
Status: Enrolling
Updated: 6/14/2012
Baptist Memorial Hospital
mi
from
Memphis, TN
Click here to add this to my saved trials
Effect of CER-001 on Atherosclerosis in Acute Coronary Syndrome (ACS) Patients - Efficacy and Safety: The CHI SQUARE Trial
CHI SQUARE: Can HDL Infusions Significantly Quicken Atherosclerosis Regression? A Phase II, Multi-Center, Double-Blind, Ascending Dose, Placebo-Controlled, Dose-Finding Trial of CER-001 or Placebo in Subjects With Acute Coronary Syndrome
Status: Enrolling
Updated:  6/14/2012
Dallas VA Medical Center
mi
from
Dallas, TX
Effect of CER-001 on Atherosclerosis in Acute Coronary Syndrome (ACS) Patients - Efficacy and Safety: The CHI SQUARE Trial
CHI SQUARE: Can HDL Infusions Significantly Quicken Atherosclerosis Regression? A Phase II, Multi-Center, Double-Blind, Ascending Dose, Placebo-Controlled, Dose-Finding Trial of CER-001 or Placebo in Subjects With Acute Coronary Syndrome
Status: Enrolling
Updated: 6/14/2012
Dallas VA Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Effect of CER-001 on Atherosclerosis in Acute Coronary Syndrome (ACS) Patients - Efficacy and Safety: The CHI SQUARE Trial
CHI SQUARE: Can HDL Infusions Significantly Quicken Atherosclerosis Regression? A Phase II, Multi-Center, Double-Blind, Ascending Dose, Placebo-Controlled, Dose-Finding Trial of CER-001 or Placebo in Subjects With Acute Coronary Syndrome
Status: Enrolling
Updated:  6/14/2012
MultiCare Health System Research Institute / Cardiac Study Center
mi
from
Tacoma, WA
Effect of CER-001 on Atherosclerosis in Acute Coronary Syndrome (ACS) Patients - Efficacy and Safety: The CHI SQUARE Trial
CHI SQUARE: Can HDL Infusions Significantly Quicken Atherosclerosis Regression? A Phase II, Multi-Center, Double-Blind, Ascending Dose, Placebo-Controlled, Dose-Finding Trial of CER-001 or Placebo in Subjects With Acute Coronary Syndrome
Status: Enrolling
Updated: 6/14/2012
MultiCare Health System Research Institute / Cardiac Study Center
mi
from
Tacoma, WA
Click here to add this to my saved trials
Effectiveness of an Exercise Program at Improving Heart and Lung Function in People With an Implantable Cardioverter Defibrillator (ICD)
Anti-Arrhythmic Effects of Exercise After an Implantable Cardioverter Defibrillator (ICD)
Status: Enrolling
Updated:  6/19/2012
Univ of Washington
mi
from
Seattle, WA
Effectiveness of an Exercise Program at Improving Heart and Lung Function in People With an Implantable Cardioverter Defibrillator (ICD)
Anti-Arrhythmic Effects of Exercise After an Implantable Cardioverter Defibrillator (ICD)
Status: Enrolling
Updated: 6/19/2012
Univ of Washington
mi
from
Seattle, WA
Click here to add this to my saved trials
EXCEL Clinical Trial (Universal Registry)
Status: Enrolling
Updated:  6/19/2012
Abbott Vascular
mi
from
Santa Clara, CA
EXCEL Clinical Trial (Universal Registry)
Status: Enrolling
Updated: 6/19/2012
Abbott Vascular
mi
from
Santa Clara, CA
Click here to add this to my saved trials
Analysis of Growth Factors in Patients Undergoing Lucentis or Avastin Injections for Diabetic Macular Edema and Exudative Macular Degeneration
Analysis of Growth Factors in Patients Undergoing Lucentis or Avastin Injections for Diabetic Macular Edema and Exudative Macular Degeneration
Status: Enrolling
Updated:  6/19/2012
Vitreo-Retinal Associates
mi
from
Grand Rapids, MI
Analysis of Growth Factors in Patients Undergoing Lucentis or Avastin Injections for Diabetic Macular Edema and Exudative Macular Degeneration
Analysis of Growth Factors in Patients Undergoing Lucentis or Avastin Injections for Diabetic Macular Edema and Exudative Macular Degeneration
Status: Enrolling
Updated: 6/19/2012
Vitreo-Retinal Associates
mi
from
Grand Rapids, MI
Click here to add this to my saved trials
Kidney Damage in Patients With Moderate Fall in eGFR
A Phase IV Pilot Study to Evaluate Kidney Damage Measured by Neutrophil Gelatinase-Associated Lipocalin (NGAL) as a New Bio-Marker in Patients With Moderate Fall in eGFR Undergoing Percutaneous Coronary Intervention With IOPAMIDOL Injection 370 or IODIXANOL 320
Status: Enrolling
Updated:  6/20/2012
Clinical Research Facility
mi
from
Park Ridge, IL
Kidney Damage in Patients With Moderate Fall in eGFR
A Phase IV Pilot Study to Evaluate Kidney Damage Measured by Neutrophil Gelatinase-Associated Lipocalin (NGAL) as a New Bio-Marker in Patients With Moderate Fall in eGFR Undergoing Percutaneous Coronary Intervention With IOPAMIDOL Injection 370 or IODIXANOL 320
Status: Enrolling
Updated: 6/20/2012
Clinical Research Facility
mi
from
Park Ridge, IL
Click here to add this to my saved trials
Kidney Damage in Patients With Moderate Fall in eGFR
A Phase IV Pilot Study to Evaluate Kidney Damage Measured by Neutrophil Gelatinase-Associated Lipocalin (NGAL) as a New Bio-Marker in Patients With Moderate Fall in eGFR Undergoing Percutaneous Coronary Intervention With IOPAMIDOL Injection 370 or IODIXANOL 320
Status: Enrolling
Updated:  6/20/2012
Priarie Cardiovascular Consultants
mi
from
Springfield, IL
Kidney Damage in Patients With Moderate Fall in eGFR
A Phase IV Pilot Study to Evaluate Kidney Damage Measured by Neutrophil Gelatinase-Associated Lipocalin (NGAL) as a New Bio-Marker in Patients With Moderate Fall in eGFR Undergoing Percutaneous Coronary Intervention With IOPAMIDOL Injection 370 or IODIXANOL 320
Status: Enrolling
Updated: 6/20/2012
Priarie Cardiovascular Consultants
mi
from
Springfield, IL
Click here to add this to my saved trials
Improving Care of Patients With Heart Failure
A Randomized Controlled Trial for Patients With Heart Failure
Status: Enrolling
Updated:  6/26/2012
UCSF Medical Center
mi
from
San Francisco, CA
Improving Care of Patients With Heart Failure
A Randomized Controlled Trial for Patients With Heart Failure
Status: Enrolling
Updated: 6/26/2012
UCSF Medical Center
mi
from
San Francisco, CA
Click here to add this to my saved trials
Evaluation of the Effect of Vitreous Composition Determined by Ultrasound and Optical Coherence Tomography (OCT) on Ranibizumab Therapy
Evaluation of the Effect of Vitreous Composition Determined by Ultrasound and Optical Coherence Tomography (OCT) on Ranibizumab Therapy
Status: Enrolling
Updated:  6/26/2012
Vision Research Foundation
mi
from
Royal Oak, MI
Evaluation of the Effect of Vitreous Composition Determined by Ultrasound and Optical Coherence Tomography (OCT) on Ranibizumab Therapy
Evaluation of the Effect of Vitreous Composition Determined by Ultrasound and Optical Coherence Tomography (OCT) on Ranibizumab Therapy
Status: Enrolling
Updated: 6/26/2012
Vision Research Foundation
mi
from
Royal Oak, MI
Click here to add this to my saved trials
Functional Change in Endothelium After Cardiac cAtheterization, With and Without Music Therapy
FEAT: Functional Change in Endothelium After Cardiac cAtheterization, With and Without Music Therapy
Status: Enrolling
Updated:  6/28/2012
Dallas VA Medical Center
mi
from
Dallas, TX
Functional Change in Endothelium After Cardiac cAtheterization, With and Without Music Therapy
FEAT: Functional Change in Endothelium After Cardiac cAtheterization, With and Without Music Therapy
Status: Enrolling
Updated: 6/28/2012
Dallas VA Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Pre and or Post Operative Blood Pressure Control With Clevidipine (Cleviprexm Medicines Company) in Aortic Aneurysm / Dissection
Pre and or Post Operative Blood Pressure Control With Clevidipine (Cleviprexm Medicines Company) in Aortic Aneurysm / Dissection.
Status: Enrolling
Updated:  6/29/2012
Duke Univ Med Ctr
mi
from
Durham, NC
Pre and or Post Operative Blood Pressure Control With Clevidipine (Cleviprexm Medicines Company) in Aortic Aneurysm / Dissection
Pre and or Post Operative Blood Pressure Control With Clevidipine (Cleviprexm Medicines Company) in Aortic Aneurysm / Dissection.
Status: Enrolling
Updated: 6/29/2012
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Feasibility Study of the LVIS™ (Low-profile Visualized Intraluminal Support)Device
A Feasibility Study of the MicroVention,Inc.(LVIS™) Neurovascular Self-Expanding Retrievable Stent System in the Treatment of Wide-Necked Intracranial Artery Aneurysms
Status: Enrolling
Updated:  6/29/2012
Albany Medical College
mi
from
Albany, NY
Feasibility Study of the LVIS™ (Low-profile Visualized Intraluminal Support)Device
A Feasibility Study of the MicroVention,Inc.(LVIS™) Neurovascular Self-Expanding Retrievable Stent System in the Treatment of Wide-Necked Intracranial Artery Aneurysms
Status: Enrolling
Updated: 6/29/2012
Albany Medical College
mi
from
Albany, NY
Click here to add this to my saved trials
Feasibility Study of the LVIS™ (Low-profile Visualized Intraluminal Support)Device
A Feasibility Study of the MicroVention,Inc.(LVIS™) Neurovascular Self-Expanding Retrievable Stent System in the Treatment of Wide-Necked Intracranial Artery Aneurysms
Status: Enrolling
Updated:  6/29/2012
Stony Brook University Medical Center
mi
from
Stony Brook, NY
Feasibility Study of the LVIS™ (Low-profile Visualized Intraluminal Support)Device
A Feasibility Study of the MicroVention,Inc.(LVIS™) Neurovascular Self-Expanding Retrievable Stent System in the Treatment of Wide-Necked Intracranial Artery Aneurysms
Status: Enrolling
Updated: 6/29/2012
Stony Brook University Medical Center
mi
from
Stony Brook, NY
Click here to add this to my saved trials
Feasibility Study of the LVIS™ (Low-profile Visualized Intraluminal Support)Device
A Feasibility Study of the MicroVention,Inc.(LVIS™) Neurovascular Self-Expanding Retrievable Stent System in the Treatment of Wide-Necked Intracranial Artery Aneurysms
Status: Enrolling
Updated:  6/29/2012
Thomas Jefferson Hospital
mi
from
Philadelphia, PA
Feasibility Study of the LVIS™ (Low-profile Visualized Intraluminal Support)Device
A Feasibility Study of the MicroVention,Inc.(LVIS™) Neurovascular Self-Expanding Retrievable Stent System in the Treatment of Wide-Necked Intracranial Artery Aneurysms
Status: Enrolling
Updated: 6/29/2012
Thomas Jefferson Hospital
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Feasibility Study of the LVIS™ (Low-profile Visualized Intraluminal Support)Device
A Feasibility Study of the MicroVention,Inc.(LVIS™) Neurovascular Self-Expanding Retrievable Stent System in the Treatment of Wide-Necked Intracranial Artery Aneurysms
Status: Enrolling
Updated:  6/29/2012
Medical University of South Carolina
mi
from
Charleston, SC
Feasibility Study of the LVIS™ (Low-profile Visualized Intraluminal Support)Device
A Feasibility Study of the MicroVention,Inc.(LVIS™) Neurovascular Self-Expanding Retrievable Stent System in the Treatment of Wide-Necked Intracranial Artery Aneurysms
Status: Enrolling
Updated: 6/29/2012
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
Feasibility Study of the LVIS™ (Low-profile Visualized Intraluminal Support)Device
A Feasibility Study of the MicroVention,Inc.(LVIS™) Neurovascular Self-Expanding Retrievable Stent System in the Treatment of Wide-Necked Intracranial Artery Aneurysms
Status: Enrolling
Updated:  6/29/2012
Memphis University Hospital
mi
from
Memphis, TN
Feasibility Study of the LVIS™ (Low-profile Visualized Intraluminal Support)Device
A Feasibility Study of the MicroVention,Inc.(LVIS™) Neurovascular Self-Expanding Retrievable Stent System in the Treatment of Wide-Necked Intracranial Artery Aneurysms
Status: Enrolling
Updated: 6/29/2012
Memphis University Hospital
mi
from
Memphis, TN
Click here to add this to my saved trials
Feasibility Study of the LVIS™ (Low-profile Visualized Intraluminal Support)Device
A Feasibility Study of the MicroVention,Inc.(LVIS™) Neurovascular Self-Expanding Retrievable Stent System in the Treatment of Wide-Necked Intracranial Artery Aneurysms
Status: Enrolling
Updated:  6/29/2012
UT Southwestern
mi
from
Dallas, TX
Feasibility Study of the LVIS™ (Low-profile Visualized Intraluminal Support)Device
A Feasibility Study of the MicroVention,Inc.(LVIS™) Neurovascular Self-Expanding Retrievable Stent System in the Treatment of Wide-Necked Intracranial Artery Aneurysms
Status: Enrolling
Updated: 6/29/2012
UT Southwestern
mi
from
Dallas, TX
Click here to add this to my saved trials
Feasibility Study of the LVIS™ (Low-profile Visualized Intraluminal Support)Device
A Feasibility Study of the MicroVention,Inc.(LVIS™) Neurovascular Self-Expanding Retrievable Stent System in the Treatment of Wide-Necked Intracranial Artery Aneurysms
Status: Enrolling
Updated:  6/29/2012
Baylor College of Medicine
mi
from
Houston, TX
Feasibility Study of the LVIS™ (Low-profile Visualized Intraluminal Support)Device
A Feasibility Study of the MicroVention,Inc.(LVIS™) Neurovascular Self-Expanding Retrievable Stent System in the Treatment of Wide-Necked Intracranial Artery Aneurysms
Status: Enrolling
Updated: 6/29/2012
Baylor College of Medicine
mi
from
Houston, TX
Click here to add this to my saved trials
Feasibility Study of the LVIS™ (Low-profile Visualized Intraluminal Support)Device
A Feasibility Study of the MicroVention,Inc.(LVIS™) Neurovascular Self-Expanding Retrievable Stent System in the Treatment of Wide-Necked Intracranial Artery Aneurysms
Status: Enrolling
Updated:  6/29/2012
Houston Methodist Hospital
mi
from
Houston, TX
Feasibility Study of the LVIS™ (Low-profile Visualized Intraluminal Support)Device
A Feasibility Study of the MicroVention,Inc.(LVIS™) Neurovascular Self-Expanding Retrievable Stent System in the Treatment of Wide-Necked Intracranial Artery Aneurysms
Status: Enrolling
Updated: 6/29/2012
Houston Methodist Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
Intravenous Norepinephrine for Orthostatic Hypotension
Safety and Efficacy of Intravenous Norepinephrine for Orthostatic Hypotension
Status: Enrolling
Updated:  7/3/2012
National Institutes of Health Clinical Center
mi
from
Bethesda, MD
Intravenous Norepinephrine for Orthostatic Hypotension
Safety and Efficacy of Intravenous Norepinephrine for Orthostatic Hypotension
Status: Enrolling
Updated: 7/3/2012
National Institutes of Health Clinical Center
mi
from
Bethesda, MD
Click here to add this to my saved trials
Study to Evaluate the Safety and Activity of BB3 to Treat Heart Attack
A Phase 2 Pilot Study to Evaluate the Safety and Activity of BB3 as an Adjunct to Percutaneous Coronary Intervention (PCI) in Subjects Presenting With Acute ST Segment Elevation Myocardial Infarction (STEMI)
Status: Enrolling
Updated:  7/13/2012
Yale University Medical Center
mi
from
New Haven, CT
Study to Evaluate the Safety and Activity of BB3 to Treat Heart Attack
A Phase 2 Pilot Study to Evaluate the Safety and Activity of BB3 as an Adjunct to Percutaneous Coronary Intervention (PCI) in Subjects Presenting With Acute ST Segment Elevation Myocardial Infarction (STEMI)
Status: Enrolling
Updated: 7/13/2012
Yale University Medical Center
mi
from
New Haven, CT
Click here to add this to my saved trials
Study to Evaluate the Safety and Activity of BB3 to Treat Heart Attack
A Phase 2 Pilot Study to Evaluate the Safety and Activity of BB3 as an Adjunct to Percutaneous Coronary Intervention (PCI) in Subjects Presenting With Acute ST Segment Elevation Myocardial Infarction (STEMI)
Status: Enrolling
Updated:  7/13/2012
Minneapolis Heart Institute Foundation
mi
from
Minneapolis, MN
Study to Evaluate the Safety and Activity of BB3 to Treat Heart Attack
A Phase 2 Pilot Study to Evaluate the Safety and Activity of BB3 as an Adjunct to Percutaneous Coronary Intervention (PCI) in Subjects Presenting With Acute ST Segment Elevation Myocardial Infarction (STEMI)
Status: Enrolling
Updated: 7/13/2012
Minneapolis Heart Institute Foundation
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Clinical Evaluation of the CADenceTM System in Detection of Coronary Artery Diseases
Clinical Evaluation of the CADence System in Detection of Coronary Artery Diseases
Status: Enrolling
Updated:  7/13/2012
Iowa Heart Center
mi
from
Des Moines, IA
Clinical Evaluation of the CADenceTM System in Detection of Coronary Artery Diseases
Clinical Evaluation of the CADence System in Detection of Coronary Artery Diseases
Status: Enrolling
Updated: 7/13/2012
Iowa Heart Center
mi
from
Des Moines, IA
Click here to add this to my saved trials
Clinical Evaluation of the CADenceTM System in Detection of Coronary Artery Diseases
Clinical Evaluation of the CADence System in Detection of Coronary Artery Diseases
Status: Enrolling
Updated:  7/13/2012
Mercy Hospital
mi
from
Coon Rapids, MN
Clinical Evaluation of the CADenceTM System in Detection of Coronary Artery Diseases
Clinical Evaluation of the CADence System in Detection of Coronary Artery Diseases
Status: Enrolling
Updated: 7/13/2012
Mercy Hospital
mi
from
Coon Rapids, MN
Click here to add this to my saved trials
Clinical Evaluation of the CADenceTM System in Detection of Coronary Artery Diseases
Clinical Evaluation of the CADence System in Detection of Coronary Artery Diseases
Status: Enrolling
Updated:  7/13/2012
Univ of Minnesota
mi
from
Minneapolis, MN
Clinical Evaluation of the CADenceTM System in Detection of Coronary Artery Diseases
Clinical Evaluation of the CADence System in Detection of Coronary Artery Diseases
Status: Enrolling
Updated: 7/13/2012
Univ of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials